CTRI/2018/01/011508招募中未知
Evaluation of the impact of allele specific gene expression on therapeutic response to oral hypoglycemic drugs in type 2 diabetes - AGED
Science and Engineering Research Board SERB0 个研究点目标入组 450 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 450
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Clinically diagnosed drug naïve T2D patients (based on world health organization criteria)
排除标准
- •Patients allergic to anti hyperglycemic drugs, type 1 diabetes mellitus, maturity onset diabetes of young (MODYs), gestational diabetes mellitus and secondary diabetes (e.g. pancreatitis, hemochromatosis), clinical renal or hepatic impairment, Cardiac problems (myocardial infarction, unstable angina pectoris), uncontrolled hypertension, non ketotic hyperosmolar coma or chronic diabetic complications, use of medications that could alter glucose metabolism, malignant diseases, hematological diseases, infected with hepatitis virus, psychosis, significant digestion, autoimmune diseases and resorption disturbances acute cerebrovascular accidents within the last 6 months will be excluded from the study.
研究者
相似试验
尚未招募
不适用
Study on the influence of the key gene phenotype and the effect of qi-supplementing and blood-activating therapy on the therapeutic effect of statins in vascular dementiaVascular DementiaITMCTR2100005177Xiyuan Hospital, Chinese Academy of Traditional Chinese medicine
招募中
Unknown
Effect of genetic polymorphism on antidiabetic medication in Indian patients with Type 2 DiabetesCTRI/2023/10/058414Chellaram Diabetes Research Centre
尚未招募
不适用
Heritability in Oropharynx CancerCTRI/2019/07/020299Department of Health Research
招募中
不适用
Investigation of influence of genetic polymorphisms of drug metabolizing enzymes and transporters, including SLCO1B3 and ABCC2, on Docetaxel Pharmacokinetics in advanced Non Small Cell Lung Cancer Patientson-Small Cell Lung CancerJPRN-UMIN000003723Research institute for diseases of the chest, Kyushu University50
已完成
3 期
Sub-study on genetic markers responsible to effects of HMG-CoA reductase inhibitor preventing recurrence of strokeIschemic strokeJPRN-UMIN000008055Department of Clinical Neuroscience and Therapeutics, Hiroshima University Graduate School of Biomedical and Health Sciences1,000